SCBIO takes aim at growing the presence of women in the life sciences industry see more
While COVID-19 brought the life sciences industry squarely into the world’s spotlight, the industry has been growing rapidly around the globe — and here in South Carolina — for quite some time. From gene editing and stem cell research to health data analytics and telemedicine, amazing advances in next generation pharmaceuticals and vaccines, medical devices, diagnostics, digital health, bio-agriculture and more are reshaping our world, while also saving and improving lives.
Life sciences in South Carolina are on a growth spurt accelerated by the pandemic. The number of firms in the industry has doubled since 2017, making it the fastest-growing industry sector in the state. The Moore School of Business estimated its annual economic impact at $12 billion and over 43,000 employees — even before COVID’s surge of growth.
To fully realize the opportunity that life sciences represent for South Carolina, the Board of Directors of SCBIO have placed a priority on increasing diversity and inclusion in the industry here at home — with action replacing perfunctory policies. Those efforts are bearing fruit.
As the official life sciences industry organization for South Carolina, SCBIO has implemented a range of commitments, actions, and programs to encourage advancement for individual women and minorities, cultivate the next generations of female leaders, and strengthen and deepen the bench of talented women workers and leaders in organizations statewide.
Among SCBIO’s numerous initiatives are:
Leading by Example – Besides my role as Interim CEO, women comprise some 25% of SCBIO’s board of directors today, which is led by a female Board Chairman, Lou Kennedy, CEO and Founder of Nephron Pharmaceuticals. The Board has also launched a new Life Sciences Diversity, Equity, and Inclusion Council to support leadership development of women and minorities. The 2021-2022 SCBIO Strategic Plan for SC Life Sciences has an entire section dedicated to encouraging expanded women and minority participation in the industry.
Relationship Building – Lt. Governor Pamela Evette, Chief External Affairs Officer for MUSC Caroline Brown, and Vikor Scientific’s Partner & Co-Founder Shea Harrelson are a few of many visible leaders actively encouraging young women to expand relationships across life sciences. This network of women leaders is deep and growing, consisting of female leaders in education, manufacturing, logistics, research, medicine, government, economic development and more who reach out to support each other’s development, share ideas, problem solve and encourage skill growth.
Supporting Career Choice for Young Women – Life science jobs are not just for M.D.s and Ph.Ds, but for technical college graduates, engineers, and biology and chemistry majors as well. With an average life sciences position paying $79,000 here, SCBIO is promoting the industry as a career path to students, guidance counselors and parents at the K-12 and two- and four-year college levels. It is also developing an industry-advocated curriculum for technical colleges covering industry prescribed manufacturing processes, safety and technical protocols, soft skills and more. A recent statewide Young Women in Life Sciences ZOOM drew over 500 high school attendees from dozens of schools across the state to learn about careers in life sciences.
Connecting Young Women – Via events and community outreach such as Virtual Meetups for women in the industry and a Women in Life Sciences Visit with our Lt. Governor, SCBIO is connecting women at all levels of life sciences organizations across the state to share information on career paths, leading teams, personal development, handling difficult conversations, encouraging innovation and more to help them connect and learn together — and encourage others they know to consider the industry as a career path.
Establishing New Partnerships – New partnerships such as serving as Presenting Sponsor of Furman University’s Women’s Leadership Institute and providing scholarships at the BMW-SYNNEX 2021 Women’s Executive Luncheon create new opportunities to have life sciences as a visible part of the discussion.
Now more than ever, women in life sciences are leading the way to the industry’s rapid growth and expansion in South Carolina… and around the world. Here at home, SCBIO is working to inspire women of all ages to choose, grow and thrive in this dynamic industry by relying on, inspiring and supporting each other to attain even greater levels of success.
The future is bright and getting even brighter as more women step up to lead the way to a brighter tomorrow.
Former Toyota executive to drive university’s innovation agenda see more
Furman University has taken another step to deeply engage its students and the greater Greenville community in innovation and entrepreneurship by naming Anthony Herrera the university’s first chief innovation officer, effective July 1.
In his new role, Herrera will create opportunities for undergraduate students to engage in entrepreneurial and innovative activities, build corporate and professional development certificates and drive the university’s innovation agenda.
He will also continue in his role as executive director of the Furman Institute for Innovation and Entrepreneurship (Furman I&E), which has built a strong foundation of relationships with public and private organizations and community leaders in Greenville, the Upstate and across South Carolina.
“Anthony has led the way in creating an innovation and entrepreneurial environment at Furman, both within the university and with state and local organizations,” said Furman University President Elizabeth Davis. “This new title recognizes the work that Anthony has already been doing — expanding and enhancing opportunities for students and helping our university work more innovatively with the community.”
Other universities across the country are creating chief innovation officer positions. The new roles reflect a convergence of factors happening in higher education, Herrera said.
“There is a need to deliver increased value and more opportunities for students, to be a contributor to communities in solving our greatest challenges, and to do this in ways that are financially sustainable,” he said.
For Furman, Herrera said, Greenville is becoming distinguished as an innovation and entrepreneurial hub among mid-size cities, “so the city’s putting intentional effort and resources toward this and the university can come alongside and be catalytic for greater impact. When the university and the city work together for common goals, everyone wins.”
As Greenville thrives, the opportunities for students include increased internship and job placements, and access to expert speakers and mentors from the business and non-profit sectors. Meanwhile, Furman continues to be a source of talent for the local area.
Herrera also will lead an effort to increase the offering of corporate and professional development programs and non-degree certificate programs, such the Women’s Leadership Institute, Design Thinking and Adaptive Leadership.
Furman I&E, which was named an Outstanding Emerging Entrepreneurship Center in 2020 by the Global Consortium of Entrepreneurship Centers, has already established relationships with area innovation organizations. In December 2020, Furman I&E joined the City of Greenville’s economic development team, NEXT and VentureSouth, to co-locate in offices in downtown. It also will launch this fall a program called GVL Starts, an eight-week experience that teaches community members how to launch a successful venture and provides access to coaching, mentoring and start-up grants needed to make it happen. The Greenville Local Development Corporation, the South Carolina Department of Commerce, the City of Greenville and Venture South are all partners in the program.
“This is an exciting opportunity to be a part of a leading liberal arts and sciences university in a city that is being recognized on a national and global level, and at a time that is such a pivotal moment in higher education,” Herrera said. “Furman has all the right ingredients to be a national leader in the space of innovation and entrepreneurship and an integral partner to the city and Upstate’s entrepreneurial and innovation community.”
Before coming to Furman in 2018, Herrera spent more than 18 years in talent management and development roles for global organizations, including as the former leader for Toyota Motor North America’s executive succession and leadership development team. Prior to Toyota, Herrera served as the executive director at SMU Cox School of Business and launched a nationally recognized center of excellence assisting Fortune 1,000 and non-profits recruit, retain and develop diverse leaders. Herrera earned his bachelor’s and master’s degrees in accounting from the SMU Cox School of Business.
SCBIO webinar generates stance from SC Senator Lindsey Graham on repatriation see more
South Carolina's senior Sen. Lindsey Graham introduced legislation last week that he cited as important during a recent SCBIO webinar, saying it will make sure that essential medical personal protective equipment is made in America.
With support from other senators, Sen. Graham introduced the U.S. Made Act of 2020 to “decrease U.S. dependence on countries like China for personal protective equipment for our health care providers."
“With the spread of coronavirus, the inability of the United States to be self-sufficient with our supply of PPE has shown itself to be a national security issue,” he stated. “Just as the United States does not rely on China to supply military uniforms or equipment, we must not rely on them to supply PPE.”
Items declared national priorities include testing swabs, surgical and respirator masks, face shields, surgical and isolation gowns, sanitizing and disinfecting wipes, gauzes and bandages, and privacy curtains, beds and bedding.
The bill also outlines personal protective equipment acquisition requirements for the Strategic National Stockpile, and establishes an investment credit for qualifying personal protective equipment manufacturing projects.
“Coronavirus has been a painful wake-up call that we are too reliant on nations like China for critical medical supplies,” Sen. Graham noted. “Without changes, China remains set to dominate the PPE market for years to come. We have seen firsthand the problems not having a reliable source of PPE places on our health care system. The Chinese grip on this critical supply chain must come to an end, and this legislation accomplishes that goal.”
Mike Briggs of Central SC Alliance passes away from cancer see more
Earlier this week, South Carolina life sciences and our state in general lost one of its great economic development champions. Mike Briggs, former president and CEO of the Central SC Alliance, passed away following a valiant battle with cancer.
Mike began what would become a two-plus decade tenure with the Central SC Alliance in 1997, just three years after the organization’s inception. Alongside the organization’s members and stakeholders, he worked tirelessly in the collaborative regional effort to attract and grow industry within Central SC’s footprint. His participation and early adoption of statewide marketing initiatives helped expand the voice of the region and South Carolina, both domestically and globally. He was a strong champion of and friend to South Carolina's life sciences community as well.
Known for warm welcomes and unmatched hospitality, Mike was recognized as a trailblazer in economic development. And while success was important, he always kept family in focus and was quick to inquire about significant life events (weddings, babies and the like). He retired this June after 23 years of service.
Mike was a longtime friend and colleague to many in South Carolina’s business community, and he leaves a lasting legacy. The life sciences community and SCBIO extend our sincere condolences to the Briggs family.
SCRA funds organizations for their COVID work see more
In response to the COVID-19 pandemic, the South Carolina Research Authority (SCRA) and its investment affiliate, SC Launch, Inc. have dedicated an additional $1.5 million in funding to support businesses that are providing coronavirus-related solutions and to help their current portfolio companies continue to meet their financial goals during this time.
Companies receiving funding to provide COVID-19 solutions are:
- Blue Eye Soft (COVID-19 detection and diagnosis)
- Carolina Diagnostic Solutions (pulmonary self-monitoring tools)
- Citibot (citizen engagement solution)
- Elastrin Therapeutics (treatment of lung-related illnesses)
- Pure Aqua Solution (destruction of pathogens including COVID-19)
- Precision Genetics (COVID-19 testing)
- Resiliency Technology, Inc. dba SHARPEN (mental health support for healthcare workers)
- Zylö Therapeutics (treatment of COVID-19 and other lung related illnesses)
Additional companies have received investments to help them continue growing their companies in spite of the pandemic. These are:
- ActiveEd (Walkabout app promoting learning and physical activity)
- BandwagonFanClub (fan demographic reporting to elevate event experiences)
- Ellipsis Technologies (anti-fraud and other cybersecurity tools)
- Global Transplant Solutions (organ preservation products)
- PEC360 (patient experience software)
- REsimplifi (commercial real estate property search)
“Our mission of fueling South Carolina’s innovation economy includes answering the call to help during this COVID-19 pandemic. Many of our current client companies were already providing or developing solutions related to COVID-19 while others quickly pivoted to address the pandemic. We are proud to be able to provide the support necessary to maximize the impact of these solutions,” said Bob Quinn, Executive Director of SCRA.
In addition to investing financially, SCRA is also involved in other initiatives to help fight the COVID-19 pandemic. Staff members are serving on various taskforces and committees with health systems and economic development organizations. Other SCRA-supported companies are providing solutions to the pandemic including Modjoul, which has developed an employee health screening platform, Humimic Medical and ZVerse, which are producing protective shields, and Vikor Scientific, which is providing respiratory pathogen testing. Lastly, SCRA is sharing COVID-19 resources online and through social media.
Chartered in 1983 by the State of South Carolina as a public, nonprofit corporation SCRA is a state-chartered organization that fuels job creation and grows South Carolina’s innovation economy. Through SCRA’s programs, SC Academic Innovations, SC Facilities, SC Launch and SC Ventures, researchers, developers and early-stage companies are receiving mentoring and funding, and may be eligible for an investment from SCRA’s investment affiliate, SC Launch, Inc.
ZVerse and Phoenix Specialty Manufacturing step up for South Carolina see more
Two South Carolina companies -- ZVerse and Phoenix Specialty Manufacturing -- jumped into action to meet the needs of the response to the coronavirus, manufacturing vital pieces of equipment at a time when they were urgently needed and unlikely to be easily available for import.
In doing so, they played key roles as the country rushed to provide the medical supplies needed to protect the lives of the sick and their caregivers.
In Columbia, ZVerse began March as a company that helped manufacturers by creating more effective computer files for their production processes. It had the capability to do some 3D printing but did not usually do manufacturing.
AVX stepping up to fight COVID-19 crisis see more
To meet the rapid increase in customer demand for critical medical equipment such as lung ventilators, mobile x-ray, CT systems, ultrasound, and patient monitors, AVX is preparing its plants to actively support the manufacture of all required components to produce the medical equipment needed to prevent the further spread of the COVID-19 virus and treat those who have been infected.
AVX provides a wide range of components that are critical to medical electronics in general and specifically ventilators. AVX NTCs measure gas and patient temperature. Tantalum and ceramic capacitors as well as Schottky diodes are used throughout the power supply system that powers the pumps, motors, displays, and control logic in ventilators. TransGuards are used as transient voltage protection on interfaces, keyboards, touch screens and audio alarms.
AVX provides a wide range of components that are critical to medical electronics in general and specifically ventilators. (Credit: AVX)
“All of us, at every level, function and business, feel the significance and the intensity surrounding the worldwide COVID-19 pandemic situation, both in our personal and professional lives. Teams across the company have been meeting daily to address critical employee and customer issues. What motivates AVX every day is knowing that despite the current situation, we are rising to the challenge as our manufacturing plants continue to deliver for our customers around the globe,” the company notes.
In a recent example, AVX has committed to fast delivery of high-grade tantalum capacitors from its plant in Lanskroun, Czech Republic, directly to UK Smith Medical company in urgent need for building 10,000 ventilators for hospitals and healthcare institutions. The requirement for three TRJ series part types were processed with top urgency to deliver it in the shortest term while keeping its high-quality standard.
According to the company, the plants continue to give their best effort to deliver all parts as soon as possible, with the shortest possible lead times with a focus on functioning effectively and efficiently to minimize all delays.
Gain inspiration from today Monday Moment from SCBIO see more
SCBIO's latest Monday Moment arrives amidst the COVID-19 storm to provide meaningful and inspiring information in 2 minutes or less. This week, enjoy an uplifting reminder from Womble Bond Dickinson's Stephanie Few that we're all in this together, plus helpful webinars, news on how SC is stepping up, and more good news to kickstart your day...
Spartanburg Regional's Gibbs Cancer Center to open expanded facility see more
With a seven-story, $72 million expansion set to open on March 16, Spartanburg Regional Healthcare System’s Gibbs Cancer Center plans to offer patients treatment beyond traditional chemotherapy and radiation.
At a ribbon-cutting held Thursday, staff unveiled the 191,000-square-foot expansion. The center includes a new physical therapy gym, patient accessible-kitchen, retail shop featuring wigs and prosthesis-fitting services and an on-site outpatient pharmacy. The facility offers radiation, medical and surgical oncology along with cyber knife technologies, centralized lab services, genetic counseling and an integrative medicine center.
“We’re blessed in the Upstate to have a world-class cancer center here that enables patients not to have to travel far,” said Tony Kouskolekas, Pelham Medical Center’s president. “They are able to get first-quality opinions and recommendations on cancer care, and what makes us a little different is that our doctors are committed to what we call multi-disciplinary care. Historically, they have gotten together to discuss someone’s case once someone was diagnosed with cancer. Now, the design of this building will allow them to come together while patients are in the building for multidisciplinary clinics, so that patients can get opinions from multiple providers while they are here for one visit.”
Kouskolekas expects that the center will bring 80 jobs to the area in its first stages, but notes that there is plenty of room to grow as needed.
“To be involved with the planning of this and working with our cancer team has just been another great facet, Kouskolekas said. “Our campus is poised for growth: we have plenty of land and so if we need to do something, we certainly can.”
According to Dr. Michael Starnes, Gibbs Cancer Center’s radiation oncology director, 36 exam rooms have been reserved for the March 16 opening, bringing the center to 75% capacity. Starnes said the center prioritizes clinical research and holistic care alongside traditional treatment measures. The integrative medicine center will allow patients a bridge to recovery through massage and art therapy, tai chi and cooking classes recorded for outpatient survivors to follow.
The new space raises the center’s capacity from less than 10 infusion treatment beds to 40 treatment rooms.
Dr. Heather Allen, a radiology oncologist at Gibbs Cancer Center, noted that the new facility streamlines and strengthens collaborative treatment opportunities spearheaded by oncologists Drs. James Bearden and Julian Josey when they founded the Gibbs Cancer Center 40 years ago.
“They were ahead of the game. This is the model that works, but it wasn’t in place 40 years ago. It was their vision to take a new paradigm shift in cancer treatment and bring it home to the local area,” Allen said.
Husman launches new quality and compliance consultancy see more
Dr. David Husman has launched David Husman Consulting, LLC, a company that assists manufacturers with quality and compliance within the pharmaceutical, biopharmaceutical, and biotech industries. Services include quality program development, compliance auditing, remediation, and training.
Serving as president and principal consultant of the company, Dr. Husman holds a doctorate degree in biochemistry and has more than 30 years of diverse international experience in quality assurance, quality control, and regulatory affairs within the pharmaceutical, biopharmaceutical, and biotech industries. Before beginning David Husman Consulting, he was a principal consultant with Parexel Consulting. He also has served previously in leadership roles in quality assurance, quality control, and regulatory affairs.
Dr. Husman is certified in Good Manufacturing Practices and regulatory affairs. He earned his doctorate and bachelor’s degree in biochemistry from The Ohio State University in Columbus, Ohio. He is a long-term member of various professional organizations, including the Regulatory Affairs Professional Society, Parenteral Drug Association, American Society for Quality, and the S.C. Biotechnology Innovation Organization.
David Husman Consulting began accepting clients as of February 1, 2020. For more information, visit DavidHusmanConsulting.com.
Many major life science firms have made the move to the Charleston region, and more are on the way see more
Compliments of Industry Today
December 19, 2019
Charleston leads the nation for job growth in scientific R&D firms. In the past two decades, major life science firms have made the move to the Charleston region. Charleston is home to 75+ medical device and pharmaceutical manufacturers, research laboratories and service companies. Life science executives across the globe are discovering that the Charleston region offers what many other larger, oversaturated markets cannot: a lifestyle that attracts and retains top talent, easy connections to life science and healthcare executives, and business-friendly regional and state support.
Read the full article HERE.
AVX Receives the South Carolina Life Sciences Pinnacle Award for Organizational Contribution at SCBIO 2019AVX received state's top life sciences award for 2019 see more
AVX Corporation, a leading manufacturer and supplier of advanced electronic components and interconnect, sensor, control, and antenna solutions, was honored with the South Carolina Life Sciences Pinnacle Award for Organizational Contribution at the 2019 SCBIO Annual Conference, which was held October 29–31 in Greenville, South Carolina. Bestowed by SCBIO Life Sciences Industry, an investor-driven economic development organization exclusively focused on building, advancing, and growing the life sciences industry in South Carolina, the distinguished award recognizes AVX’s significant contributions to the advancement of the state’s $11.4 billion life sciences industry, including its vast and ever-expanding portfolio of innovative electronic components and interconnect solutions for high-reliability medical applications.
“The life sciences industry is a significant driver of South Carolina’s growing knowledge economy,” said SCBIO President and CEO Sam Konduros, “so we’re very pleased to honor AVX as a SCBIO Mission Partner and 2019 award recipient for their exceptional contributions to the advancement of life sciences. AVX has demonstrated a sustained commitment to developing innovative, high-reliability, and high-performance components that have earned the trust of a majority of implantable life support device manufacturers worldwide.”
With more than 20 years of proven high-reliability performance in the medical industry, AVX is widely recognized as a leading global supplier of medical-grade components, including advanced tantalum and ceramic capacitors, thin film passives, filters, connectors, and multi-pin arrays — all of which are manufactured in ISO 9001 facilities using strict manufacturing control, statistical screening, and testing procedures compliant with rigorous FDA quality and safety regulations. The company’s extensive range of high-reliability medical solutions enables a wide range of both critical and non-critical medical applications, ranging from Class III implantable and life-sustaining devices including pacemakers, implantable cardioverter-defibrillators (ICDs), neurostimulators, neuromodulation devices, and external heart pump controls to Class I and II devices including cochlear implants, insulin pumps, drug pumps, hearing aids, heart monitors, vascular-assist devices, MRI and X-ray machines, external defibrillators, and other patient monitoring and diagnostic devices.
“We are honored to have been presented with the South Carolina Life Sciences Pinnacle Award for Organizational Contribution by such a valued mission partner as SCBIO,” said Robert Fairey, vice president of the AVX Medical Division. “AVX is dedicated to delivering top-quality, cutting-edge component technologies that meet or exceed the stringent specifications and requirements set forth by the medical industry and is actively engaged in the continued expansion of these highly specialized passive component and interconnect product portfolios.”
Fairey represented AVX at this year’s SCBIO conference, which provided a record gathering of 450 life sciences industry experts, thought leaders, and executives from 11 countries, 32 states, and nearly every county in South Carolina with valuable information exchange and networking opportunities.
For more information about AVX, please visit www.avx.com, email email@example.com, follow them on LinkedIn and Twitter, like them on Facebook, call 864-967-2150, or write to One AVX Boulevard, Fountain Inn, S.C. 29644.
AVX Corporation is a leading international manufacturer and supplier of advanced electronic components, interconnect, sensing, control, and antenna solutions with 29 manufacturing facilities in 16 countries around the world. AVX offers a broad range of devices including capacitors, resistors, filters, couplers, sensors, controls, circuit protection devices, connectors, and antennas. The company is publicly traded on the New York Stock Exchange (NYSE:AVX).
Alcami's $17 million investment is expected to create 30 new jobs see more
Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biologics industries, today announced plans to expand the company’s current operations in Charleston County. The $17 million investment is expected to create 30 new jobs.
Operating in North Charleston since 2001, Alcami offers a variety of solutions tailored to small and midsized pharmaceutical and biotechnology companies.
Located at 4221 Faber Place Drive in North Charleston, S.C., Alcami will add approximately 6,000 square feet to the footprint of its facility, substantially augmenting the capacity of its sterile drug product development and manufacturing operations.
The company’s expansion is expected to be completed in 2021. Individuals interested in joining the Alcami team should visit https://www.alcaminow.com/alcami-careers.
The Coordinating Council for Economic Development has approved job development credits related to the project.
“The build-out of our Charleston facility comes at a time of rapid growth for Alcami and represents a long-term commitment to our sterile drug product clients, our talented workforce and the greater Charleston area. Our clients expect the most advanced manufacturing technologies and capabilities, and this expansion will ensure we continue to exceed marketplace expectations by remaining on the forefront of industry needs.” -Alcami Site Director Darold Hill
“When a company like Alcami Corporation continues to invest in our state and our people, it shows the businesses around the world that South Carolina is the place to be. We look forward to seeing this great company continue to grow and thrive for years to come.” –Gov. Henry McMaster
“We’re excited to see the continued success of Alcami Corporation in Charleston County and the success of our state’s thriving manufacturing industry. We congratulate them on this newest announcement and the creation of 30 new jobs.” –Secretary of Commerce Bobby Hitt
“The growth of Alcami Corporation during its 18 years in North Charleston has been truly remarkable. This company is a highly-valued corporate citizen, and with this expansion, it is renewing its steadfast and long-standing commitment to our community.” –Charleston County Council Chairman Elliott Summey
“We applaud Alcami’s accomplishments in our local economy, building upon their company’s innovation, which is backed by a proven workforce. North Charleston remains ripe for businesses to flourish, and we are always grateful for the benefits our community receives when companies succeed.” –North Charleston Mayor Keith Summey
“Congratulations to Alcami on announcing their second expansion in Charleston County in the last three years. Assisting local companies in their expansion efforts is a primary focus of our Business Concierge program. Our long-standing relationship with Alcami helped support their decision to grow their global footprint at their North Charleston facility.” –Charleston County Economic Development Executive Director Steve Dykes
Greenwood Genetic Center, MUSC affiliate to improve patient access to innovations in genetic servicesMUSC partners with Greenwood Genetic Center see more
The Greenwood Genetic Center (GGC) and the Medical University of South Carolina (MUSC) have signed an affiliation agreement with the goal of providing patients across South Carolina with accessible, high-quality, coordinated and cost-effective genetic services through a collaborative approach to providing medical care. The two entities have worked together informally on clinical consultations, provider education and research for more than a decade. This affiliation seeks to formalize and expand the depth and breadth of the relationship. According to MUSC, a partnership with the state’s most advanced and innovative genetic center was an easy choice.
“I live in Greenwood, and I’ve said for years that a lot people don’t understand what an absolute gem this center is,” said Charles Schulze, chairman of the MUSC Board of Trustees. “They’ve helped almost 100,000 families across the state make incredibly important decisions, unmasked difficult-to-diagnose conditions, and have been there for these families every step of the way when faced with good news, or not so good news.”
While there are any number of reasons people may want to learn more about how their genetics may affect their or their loved ones health, all patients want the same thing: high-quality care at the lowest cost and access to the latest technologies, diagnostics and research related to their genetic stories. In the interest of better serving these needs, the initial goals of the partnership include:
- Increasing access to clinical genetic services for MUSC patients and all South Carolinians
- Optimizing the patient journey to improve wait times for appointments and consultations
- Sharing critical resources and expertise where possible to lower costs
- Pursuing workforce development, research, clinical trials and treatment collaborations.
Nearly every child in South Carolina who was diagnosed with a genetic birth defect, developmental delay or other hereditary disorder has already been referred to GGC, due to the center’s expertise with rare conditions and commitment to new technologies and diagnostics. GGC, a nonprofit institute centered on research, clinical genetic services, diagnostic laboratory testing and educational programs and resources, is focused on compassionate patient care and innovative scientific advancement.
About Greenwood Genetic Center
The Greenwood Genetic Center (GGC), founded in 1974, is a nonprofit organization advancing the field of medical genetics and caring for families impacted by genetic disease and birth defects. At its home campus in Greenwood, South Carolina, a talented team of physicians and scientists provides clinical genetic services, diagnostic laboratory testing, educational programs and resources, and research in the field of medical genetics. GGC’s faculty and staff are committed to the goal of developing preventive and curative therapies for the individuals and families they serve. GGC extends its reach as a resource to all residents of South Carolina with satellite offices in Charleston, Columbia, Florence and Greenville. For more information about GGC please visit www.ggc.org.
Nephron partnership helps patients receive anesthetics faster see more
A new partnership between Nephron Pharmaceuticals Corp. and National Medical Products Inc. will help provide more patients with a quick and simple delivery of anesthetic medications, according to a news release from Nephron.
National Medical Products is the developer of the single-use, subcutaneous J-Tip Needle-Free Injector. Hospitals which use the injector will now be able to use Nephron-developed technology in a Luer lock syringe, buffered and pre-filled with lidocaine, to fill it.
“This new partnership is a huge win for patients, and we are extraordinarily excited to announce it,” Lou Kennedy, CEO of West Columbia-headquartered Nephron, said in the release. “Working together with the developers of J-Tip, we are making sure that the delivery of anesthetic medications is safe, easy-to-use and virtually pain-free, because patients deserve nothing less.”
California-based National Medical Products, established in 2001, refined a jet-injection technology previously used by the military for vaccine delivery to create a self-contained injector that uses compressed carbon dioxide to provide an anesthetic effect in one to two minutes, according to the release. The injector is most commonly used before procedures such as IV insertions and blood draws.
Nephron said the companies hope the partnership will help reach more patients.